Durable response to selpercatinib in HOOK3‑RET fusion positive, α‑fetoprotein producing metastatic pancreatic ductal adenocarcinoma with intestinal‑type differentiation
Oncology Letters · 20.05.2026 · 32 (1) · 1-6
DOI: 10.3892/ol.2026.15661 ↗Kurz gefasst
Fallbericht in der Zeitschrift Oncology Letters, online erschienen am 20.05.2026. Verfasst von Harsahib Singh Sandhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
- Medgenome Labs Ltd., Bengaluru, Karnataka 560100, India.
- Department of Medical Oncology, Sandhu Cancer Centre, Ludhiana, Punjab 141001, India.
Zitieren
APA
Sandhu, H. S., Natarajan, A., & Joshi, S. (2026). Durable response to selpercatinib in HOOK3‑RET fusion positive, α‑fetoprotein producing metastatic pancreatic ductal adenocarcinoma with intestinal‑type differentiation. Oncology Letters, 32(1), 1-6. https://doi.org/10.3892/ol.2026.15661
Vancouver
Sandhu HS, Natarajan A, Joshi S. Durable response to selpercatinib in HOOK3‑RET fusion positive, α‑fetoprotein producing metastatic pancreatic ductal adenocarcinoma with intestinal‑type differentiation. Oncology Letters. 2026;32(1):1-6. doi:10.3892/ol.2026.15661
BibTeX
@article{Sandhu2026,
author = {Sandhu, Harsahib Singh and Natarajan, Aparna and Joshi, Smiley},
title = {Durable response to selpercatinib in HOOK3‑RET fusion positive, α‑fetoprotein producing metastatic pancreatic ductal adenocarcinoma with intestinal‑type differentiation},
journal = {Oncology Letters},
year = {2026},
volume = {32},
number = {1},
pages = {1--6},
doi = {10.3892/ol.2026.15661}
}
EUVIMED